medline.ch Onkologie Gynäkologische Tumoren

	Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations. Ther Adv Med Oncol Reinert T, Alshehri AS, Shafik A, Lin CH, Gomez Abuin G, Gong G, Jung KH, Amat M, Pathmanathan N, Ow SGW, Rivera-Rivera S, Aggarwal S, Luen SJ, Yong Tay TK. PMID: 42609450 [PubMed - as supplied by publisher]
	Association between metabolic syndrome and mortality among breast cancer survivors: a prospective cohort study. Front Endocrinol (Lausanne) Zhang T, Cai X, Qian S, Huang J. PMID: 42609325 [PubMed - indexed for MEDLINE]
	Changes in Depressive Symptoms Following Mindfulness Training in Female Patients With Abdominal or Abdominopelvic Cancer: A Preliminary Non-Randomized Controlled Study. Psychooncology Kou H, Li Q, Hu X, Yue K, Xie Q, Li X, Jin Y, Lu T, Luo W, Bi T. PMID: 42609116 [PubMed - indexed for MEDLINE]
	Discovery of Breast Cancer Diagnostic Markers Using Lipase-Based Plasma Proteomics of Lipid-Bound Proteins. J Mass Spectrom Kang EJ, Choe Y, Lee KH, Lee S. PMID: 42609020 [PubMed - indexed for MEDLINE]
	Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal BreastÂ Cancer:Â A Single-Arm Clinical Trial. Int J Cancer Wu J, Liu D, Chen M, Lin C, Ding S, Hong J, Gao W, Zhu S, Chen X, Huang O, He J, Chen W, Li Y, Shen K, Zhu L. PMID: 42608991 [PubMed - as supplied by publisher]
	Association between sentinel lymph node number and prognosis in cT1-2N0M0 early breast cancer patients with negative sentinel lymph nodes: a singleâ€‘center retrospective cohort study. Ann Med Bai C, Li P, Shi C, Han Q, Fan Z, Qu F. PMID: 42608978 [PubMed - indexed for MEDLINE]
	Construction and Validation of a Risk Prediction Model for Lower Limb Lymphedema After Cervical Cancer Surgery: A Prospective Cohort Study. Cancer Med Zhao G, Xu J, Liu G, Li S, Liu X, Long J. PMID: 42608880 [PubMed - indexed for MEDLINE]
	Immunohistochemical expression of JAK2, STAT3, POLH, UBE2T, and REV7 in serous ovarian carcinoma: clinicopathological associations and co-expression patterns. J Mol Histol Farrag MS, Masoud R, Hemeda MS, Emarah Z, Naghy KE, Abdelwahab K, Farrag NS, Ibrahiem AT, Ehab Z, Elrefaie WE, Elalfy A, Hassan MK. PMID: 42608614 [PubMed - indexed for MEDLINE]
	Chronic non-puerperal uterine inversion due to submucosal fibroid. BMJ Case Rep Shrivastava SS, Kirar DB, Patel T, Rajput HN. PMID: 42608075 [PubMed - indexed for MEDLINE]
	Extranodal diffuse large B-cell lymphoma presenting as a rapidly growing palatal mass in a patient with prior breast carcinoma. BMJ Case Rep Khobragade T, Chettiankandy TJ, Sardar MA, Sachdev SS, Janardanan A. PMID: 42608071 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of organised versus opportunistic mammography breast cancer screening in low-resourced country. BMJ Open Al Rabayah A, Mandrik O, Mansour A, Al-Ajlouni R, Haddad T, Abdel-Razeq H, Shamieh O, Chalkidou K, Sullivan R, Gheorghe A. PMID: 42608043 [PubMed - indexed for MEDLINE]
	Risk of Postoperative Recurrence in Patients With Unusual Smooth Muscle Neoplasia and Construction of a Prediction Model. J Obstet Gynaecol Res Hu W, Wu S, Zhang J, Li Y, Zeng X, Xiao S. PMID: 42608026 [PubMed - indexed for MEDLINE]
	Impact of Immunotherapy Addition on Dose Density and Clinical Outcomes of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Retrospective, Real-world Study From Multiple Centers in London, UK. Clin Breast Cancer Javed R, Veli M, De Souza K, Fessas P, Millar L, Koske D, Dasgupta R, Oroko B, Muhammad R, Islam J, Rai S, Sheri A, Konstantis A, Raja F, Ottaviani D, Papadimitraki E. PMID: 42607489 [PubMed - as supplied by publisher]
	Novel Class I HDAC Inhibitors Sensitize Ovarian Cancer Cells for Cisplatin and Niraparib via an HDAC3-SLFN11 Axis. ACS Chem Biol Eichhorn JM, Menning J, Schäker-Hübner L, Hansen FK, König P, Bendas G. PMID: 42607195 [PubMed - as supplied by publisher]
	Decision coaching for healthy women with BRCA1/2 pathogenic variants and open family planning: Impact on decisional conflict and decision status: Subgroup analyses from a randomized controlled trial. PLoS One Stracke C, Kautz-Freimuth S, Shukri A, Isselhard A, Berger-Höger B, Steckelberg A, Vitinius F, Dikow N, Kiechle M, Meisel C, Wöckel A, von Mackelenbergh MT, Schmutzler R, Rhiem K, Stock S. PMID: 42607047 [PubMed - indexed for MEDLINE]
	Acceptability of breast cancer risk assessment for women aged 30-49: Views of women from six under-served groups. PLoS One Woof VG, Valasaki M, Stutzin Donoso F, McWilliams L, Morley H, Usher-Smith J, French DP. PMID: 42607025 [PubMed - indexed for MEDLINE]
	Challenging the size: ovarian-sparing surgery in borderline huge pediatric ovarian tumors. Pediatr Surg Int Mariani A, Fiorenza V, Hameury F, Goulin J, Dijoud F, Gorduza D. PMID: 42606737 [PubMed - indexed for MEDLINE]
	Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal. Ann Surg Oncol Beck AC, Carroll EF, Mukhtar RA, Cassidy MR, Flanagan MR, Gamble LA, Erdahl LM. PMID: 42606651 [PubMed - as supplied by publisher]
	Improving cervical screening risk stratification through extended human papillomavirus genotyping and age-specific data. Eur J Public Health Leino A, Numminen E, Fonagy V, Paloniemi M, Seiskari T, Kholová I, Kares S, Louvanto K. PMID: 42606565 [PubMed - indexed for MEDLINE]
	Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial. Eur J Nucl Med Mol Imaging Urso L, Panareo S, Albano D, Iudicello A, Filippi L, Borgia F, Bartolomei M, Guglielmo P, Bertagna F, Taralli S, Calcagni ML, Mazzoletti A, Bonacina M, Fantini L, Paccagnella A, Colombo CB, Castellani M, Annovazzi A, Sciuto R, Bauckneht M, Garrou F, Aricò D, Rovera G, Ferrari C, Miceli A, Reccia P, Cassarino G, Rizza E, Marongiu A, Arnone A, Maffione AM, Ialuna S, Frega N, Evangelista L, All the TRINE-PET Investigators. PMID: 42606562 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 333784

Seite 1 von 16690

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung